Other ingredients
Gelatin; Maltodextrin; Magnesium Stearate (Mg Stearate); Silica; Titanium Dioxide (TiO2)
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
FINAFLEX
Pure Test
Capsule
Serving size6 Capsule(s)
Servings per containerNot listed
Package120 Capsule(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 6 Capsule(s)
D-Aspartic Acid3 gDV not established
Label directions
Suggested use:As a dietary supplement take 1 serving (6 capsules) daily.
Label warnings
Allergen Warning: Produced in a facility that processes milk eggs soybeans wheat shellfish fish oil tree nuts sesame and peanuts. Warning: Keep out of reach of children. Intended for healthy adults over 18. Do not use if pregnant or nursing. Consult a doctor or medical authority before use if you have a medical condition a family history of health problems or if you take other medicines or supplements. Do not exceed serving size. Stop use if you have a bad reaction. Stop use after 8 weeks. Stop use 2 weeks before surgery. Consumer accepts all liability if used inconsistent with label. Do not discard desiccant. California Prop 65 Warning: Lead; Cancer and Reproductive Harm www.P65Warnings.ca.gov
Identity and label version
NIH label record333679
Entered into NIH DSLDAug 22, 2025
UPC / GTIN00810020722789
Manufacturer / distributor on labelFINAFLEX
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (1)
Current labelNIH record 333679Entered Aug 22, 2025
D-Aspartic Acid3 g
Label warning: Allergen Warning: Produced in a facility that processes milk eggs soybeans wheat shellfish fish oil tree nuts sesame and peanuts. Warning: Keep out of reach of children. Intended for healthy adults over 18. Do not use if pregnant or nursing. Consult a doctor or medical authority before use if you have a medical condition a family history of health problems or if you take other medicines or supplements. Do not exceed serving size. Stop use if you have a bad reaction. Stop use after 8 weeks. Stop use 2 weeks before surgery. Consumer accepts all liability if used inconsistent with label. Do not discard desiccant. California Prop 65 Warning: Lead; Cancer and Reproductive Harm www.P65Warnings.ca.gov
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
More from FINAFLEX
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.